MDLN — Medline Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeLarge CapNeutral

Annual income statement for Medline, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS
Standards:	USG	USG	USG
Status:	Final	Final	Final
Revenue
Total Revenue	21,448	23,231	25,507
Cost of Revenue
Gross Profit	5,217	5,885	6,976
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	20,587	21,981	23,361
Operating Profit	861	1,250	2,146
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	10	264	1,246
Provision for Income Taxes
Net Income After Taxes	-25	234	1,200
Net Income Before Extraordinary Items
Net Income	-25	234	1,200
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-25	234	1,200
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.126	0.417	1.1